Novo Integrated Sciences Inc
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, … Read more
Novo Integrated Sciences Inc (NVOS) - Total Assets
Latest total assets as of November 2024: $32.14 Million USD
Based on the latest financial reports, Novo Integrated Sciences Inc (NVOS) holds total assets worth $32.14 Million USD as of November 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Novo Integrated Sciences Inc - Total Assets Trend (2004–2024)
This chart illustrates how Novo Integrated Sciences Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Novo Integrated Sciences Inc - Asset Composition Analysis
Current Asset Composition (August 2024)
Novo Integrated Sciences Inc's total assets of $32.14 Million consist of 16.9% current assets and 83.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.6% |
| Accounts Receivable | $3.15 Million | 9.8% |
| Inventory | $1.00 Million | 3.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $13.37 Million | 41.6% |
| Goodwill | $6.55 Million | 20.4% |
Asset Composition Trend (2004–2024)
This chart illustrates how Novo Integrated Sciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Novo Integrated Sciences Inc's current assets represent 16.9% of total assets in 2024, an increase from 0.0% in 2004.
- Cash Position: Cash and equivalents constituted 2.6% of total assets in 2024, up from 0.0% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 61.0% of total assets, an increase from 0.0% in 2004.
- Asset Diversification: The largest asset category is intangible assets at 41.6% of total assets.
Novo Integrated Sciences Inc Competitors by Total Assets
Key competitors of Novo Integrated Sciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Novo Integrated Sciences Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Novo Integrated Sciences Inc generates 0.41x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Novo Integrated Sciences Inc is currently not profitable relative to its asset base.
Novo Integrated Sciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.37 | 0.62 | 1.41 |
| Quick Ratio | 0.30 | 0.51 | 1.41 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-9.16 Million | $ -4.11 Million | $ 1.22 Million |
Novo Integrated Sciences Inc - Advanced Valuation Insights
This section examines the relationship between Novo Integrated Sciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.01 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -9.6% |
| Total Assets | $32.14 Million |
| Market Capitalization | $57.13K USD |
Valuation Analysis
Below Book Valuation: The market values Novo Integrated Sciences Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Novo Integrated Sciences Inc's assets decreased by 9.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Novo Integrated Sciences Inc (2004–2024)
The table below shows the annual total assets of Novo Integrated Sciences Inc from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-08-31 | $32.14 Million | -9.62% |
| 2023-08-31 | $35.56 Million | -50.46% |
| 2022-08-31 | $71.79 Million | +15.87% |
| 2021-08-31 | $61.96 Million | +75.07% |
| 2020-08-31 | $35.39 Million | +9.66% |
| 2019-08-31 | $32.27 Million | +580.43% |
| 2018-08-31 | $4.74 Million | -13.99% |
| 2017-08-31 | $5.51 Million | +90.73% |
| 2016-09-30 | $2.89 Million | +10272.75% |
| 2016-08-31 | $27.87K | +23.38% |
| 2015-08-31 | $22.59K | -93.68% |
| 2014-08-31 | $357.72K | +935.79% |
| 2013-08-31 | $34.54K | +33.80% |
| 2012-08-31 | $25.81K | -97.83% |
| 2011-08-31 | $1.19 Million | +286.93% |
| 2010-08-31 | $306.79K | +1421.93% |
| 2009-08-31 | $20.16K | -75.61% |
| 2008-08-31 | $82.64K | +196.57% |
| 2007-08-31 | $27.87K | +1104.24% |
| 2006-08-31 | $2.31K | -97.95% |
| 2005-08-31 | $112.96K | 0.00% |
| 2004-08-31 | $112.96K | -- |